Rakuten Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1K Sell
129
-133
-51% -$29.5K 0.01% 312
2025
Q4
$59.9K Buy
262
+89
+51% +$20.3K 0.02% 225
2025
Q3
$40.1K Sell
173
-195
-53% -$39.7K 0.01% 261
2025
Q2
$68.3K Buy
368
+77
+26% +$14.3K 0.03% 196
2025
Q1
$61K Sell
291
-66
-18% -$12.8K 0.03% 197
2024
Q4
$63.4K Buy
357
+220
+161% +$40.4K 0.03% 189
2024
Q3
$27.1K Sell
137
-270
-66% -$50.4K 0.01% 231
2024
Q2
$69.8K Sell
407
-433
-52% -$71.7K 0.03% 152
2024
Q1
$153K Buy
840
+470
+127% +$81K 0.07% 104
2023
Q4
$57.3K Buy
+370
New +$53.9K 0.05% 148

Other funds holding ABBV

Rakuten Securities's ABBV Position: Q1 2026 in Review

Rakuten Securities reduced its AbbVie (ABBV) stake by 51% in Q1 2026, selling an estimated $29.5K and leaving 129 shares worth $28.1K. The position accounts for 0.01% of the portfolio, ranked #312.

Rakuten Securities first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $153K in Q1 2024. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Rakuten Securities held 129 shares of AbbVie worth $28.1K as of Q1 2026.
  • Rakuten Securities sold 133 AbbVie shares in Q1 2026, an estimated $29.5K.
  • AbbVie made up 0.01% of Rakuten Securities's portfolio in Q1 2026, its #312 holding.
  • Rakuten Securities first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Rakuten Securities's AbbVie position peaked at $153K in Q1 2024.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Rakuten Securities's 13F filing for Q1 2026, filed 1 May 2026.